CLINICAL_TRIALS
trial_result
· 2025-08-03
Clinical Trial Update: A Study of HS-20094 in T2DM Participants [Phase 2]
Summary
This Clinical Trial Update reports that the Phase 2 study of HS-20094 in Type 2 diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED